{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:09:32Z","timestamp":1749874172598,"version":"3.41.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-016-2150-6","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T04:34:09Z","timestamp":1483763649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study"],"prefix":"10.1186","volume":"17","author":[{"given":"Taro","family":"Noguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8595-8944","authenticated-orcid":false,"given":"Yasufumi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Takakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ichiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,7]]},"reference":[{"key":"2150_CR1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/14787210.6.5.657","volume":"6","author":"JD Pitout","year":"2008","unstructured":"Pitout JD. Multiresistant Enterobacteriaceae: new threat of an old problem. Expert Rev Anti Infect Ther. 2008;6:657\u201369.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2150_CR2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1469-0691.2010.03298.x","volume":"17","author":"A Courpon-Claudinon","year":"2011","unstructured":"Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, et al. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect. 2011;17:557\u201365.","journal-title":"Clin Microbiol Infect"},{"key":"2150_CR3","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1128\/JCM.02353-09","volume":"48","author":"J Rodriguez-Bano","year":"2010","unstructured":"Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Cisneros JM, Pena C, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol. 2010;48:1726\u201331.","journal-title":"J Clin Microbiol"},{"key":"2150_CR4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4212\/cjhp.v68i2.1439","volume":"68","author":"ML Nguyen","year":"2015","unstructured":"Nguyen ML, Toye B, Kanji S, Zvonar R. Risk factors for and outcomes of bacteremia caused by extended-spectrum \u00df-lactamase-producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital. Can J Hosp Pharm. 2015;68:136\u201343.","journal-title":"Can J Hosp Pharm"},{"key":"2150_CR5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jiac.2014.08.012","volume":"20","author":"S G\u00fcrntke","year":"2014","unstructured":"G\u00fcrntke S, Kohler C, Steinmetz I, Pfeifer Y, Eller C, Gastmeier P, et al. Molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-positive Klebsiella pneumoniae from bloodstream infections and risk factors for mortality. J Infect Chemother. 2014;20:817\u20139.","journal-title":"J Infect Chemother"},{"key":"2150_CR6","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/cid\/civ121","volume":"60","author":"WC Rottier","year":"2015","unstructured":"Rottier WC, Bamberg YR, Dorigo-Zetsma JW, van der Linden PD, Ammerlaan HS, Bonten MJ. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis. Clin Infect Dis. 2015;60:1622\u201330.","journal-title":"Clin Infect Dis"},{"key":"2150_CR7","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10096-015-2350-9","volume":"34","author":"ER Vlieghe","year":"2015","unstructured":"Vlieghe ER, Huang TD, Phe T, Bogaerts P, Berhin C, De Smet B, et al. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia. Eur J Clin Microbiol Infect Dis. 2015;34:1223\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2150_CR8","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/AAC.02252-12","volume":"57","author":"M Castanheira","year":"2013","unstructured":"Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN. Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother. 2013;57:3012\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"2150_CR9","volume-title":"Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. CLSI document M100-S19","author":"Clinical and Laboratory Standards Institute","year":"2009","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. CLSI document M100-S19. Wayne: CLSI; 2009."},{"key":"2150_CR10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791\u20137.","journal-title":"Ann Intern Med"},{"key":"2150_CR11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"2150_CR12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"2150_CR13","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","volume":"26","author":"JL Vincent","year":"1998","unstructured":"Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on \u201csepsis-related problems\u201d of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26:1793\u2013800.","journal-title":"Crit Care Med"},{"key":"2150_CR14","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.00404-11","volume":"49","author":"S Polsfuss","year":"2011","unstructured":"Polsfuss S, Bloemberg GV, Giger J, Meyer V, B\u00f6ttger EC, Hombach M. Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol. 2011;49:2798\u2013803.","journal-title":"J Clin Microbiol"},{"key":"2150_CR15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/dkp498","volume":"65","author":"C Dallenne","year":"2010","unstructured":"Dallenne C, Da Costa A, Decr\u00e9 D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65:490\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"2150_CR16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1099\/jmm.0.46160-0","volume":"54","author":"L Xu","year":"2005","unstructured":"Xu L, Ensor V, Gossain S, Nye K, Hawkey P. Rapid and simple detection of blaCTX-M genes by multiplex PCR assay. J Med Microbiol. 2005;54:1183\u20137.","journal-title":"J Med Microbiol"},{"key":"2150_CR17","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/AAC.46.10.3156-3163.2002","volume":"46","author":"L Bri\u00f1as","year":"2002","unstructured":"Bri\u00f1as L, Zarazaga M, S\u00e1enz Y, Ruiz-Larrea F, Torres C. Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother. 2002;46:3156\u201363.","journal-title":"Antimicrob Agents Chemother"},{"key":"2150_CR18","first-page":"53","volume":"184","author":"T Yagi","year":"2000","unstructured":"Yagi T, Kurokawa H, Shibata N, Shibayama K, Arakawa Y. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett. 2000;184:53\u20136.","journal-title":"FEMS Microbiol Lett"},{"key":"2150_CR19","first-page":"161","volume":"209","author":"M Saladin","year":"2002","unstructured":"Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, Ould-Hocine Z, et al. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett. 2002;209:161\u20138.","journal-title":"FEMS Microbiol Lett"},{"key":"2150_CR20","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","volume":"40","author":"FJ P\u00e9rez-P\u00e9rez","year":"2002","unstructured":"P\u00e9rez-P\u00e9rez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40:2153\u201362.","journal-title":"J Clin Microbiol"},{"key":"2150_CR21","doi-asserted-by":"crossref","unstructured":"Asensio A, Alvarez-Espejo T, Fernandez-Crehuet J, Ramos A, Vaque-Rafart J, Bishopberger C, et al. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010. Euro Surveill. 2011;16:12-20.","DOI":"10.2807\/ese.16.40.19983-en"},{"key":"2150_CR22","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/AAC.00971-12","volume":"57","author":"WH Sheng","year":"2013","unstructured":"Sheng WH, Badal RE, Hsueh PR, Program S. Distribution of extended-spectrum \u03b2-lactamases, AmpC \u03b2-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother. 2013;57:2981\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2150_CR23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajic.2015.02.030","volume":"43","author":"T Chopra","year":"2015","unstructured":"Chopra T, Marchaim D, Johnson PC, Chalana IK, Tamam Z, Mohammed M, et al. Risk factors for bloodstream infection caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime. Am J Infect Control. 2015;43:719\u201323.","journal-title":"Am J Infect Control"},{"key":"2150_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2015.07.010","volume":"39","author":"B Denis","year":"2015","unstructured":"Denis B, Lafaurie M, Donay JL, Fontaine JP, Oksenhendler E, Raffoux E, et al. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study. Int J Infect Dis. 2015;39:1\u20136.","journal-title":"Int J Infect Dis"},{"key":"2150_CR25","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","volume":"51","author":"M Tumbarello","year":"2007","unstructured":"Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 2007;51:1987\u201394.","journal-title":"Antimicrob Agents Chemother"},{"key":"2150_CR26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365548.2014.937454","volume":"46","author":"S Aken Van","year":"2014","unstructured":"Van Aken S, Lund N, Ahl J, Odenholt I, Tham J. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia. Scand J Infect Dis. 2014;46:753\u201362.","journal-title":"Scand J Infect Dis"},{"key":"2150_CR27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0924-8579(03)00094-3","volume":"22","author":"BN Kim","year":"2003","unstructured":"Kim BN, Lee SO, Choi SH, Kim NJ, Woo JH, Ryu J, et al. Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species. Int J Antimicrob Agents. 2003;22:106\u201311.","journal-title":"Int J Antimicrob Agents"},{"key":"2150_CR28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2334-8-116","volume":"8","author":"KA Thom","year":"2008","unstructured":"Thom KA, Schweizer ML, Osih RB, McGregor JC, Furuno JP, Perencevich EN, et al. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study. BMC Infect Dis. 2008;8:116.","journal-title":"BMC Infect Dis"},{"key":"2150_CR29","first-page":"293","volume":"26","author":"M Falcone","year":"2014","unstructured":"Falcone M, Vena A, Mezzatesta ML, Gona F, Caio C, Goldoni P, et al. Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae. Ann Ig. 2014;26:293\u2013304.","journal-title":"Ann Ig"},{"key":"2150_CR30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mayocp.2014.12.002","volume":"90","author":"S Vasoo","year":"2015","unstructured":"Vasoo S, Barreto JN, Tosh PK. Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician. Mayo Clin Proc. 2015;90:395\u2013403.","journal-title":"Mayo Clin Proc"},{"key":"2150_CR31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijantimicag.2012.04.013","volume":"40","author":"Y Matsumura","year":"2012","unstructured":"Matsumura Y, Yamamoto M, Higuchi T, Komori T, Tsuboi F, Hayashi A, et al. Prevalence of plasmid-mediated AmpC \u03b2-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum \u03b2-lactamase-producing E. coli in Japan. Int J Antimicrob Agents. 2012;40:158\u201362.","journal-title":"Int J Antimicrob Agents"},{"key":"2150_CR32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/CMR.00125-13","volume":"27","author":"MH Nicolas-Chanoine","year":"2014","unstructured":"Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543\u201374.","journal-title":"Clin Microbiol Rev"},{"key":"2150_CR33","doi-asserted-by":"crossref","first-page":"e37967","DOI":"10.1371\/journal.pone.0037967","volume":"7","author":"H Kanamori","year":"2012","unstructured":"Kanamori H, Yano H, Hirakata Y, Hirotani A, Arai K, Endo S, et al. Molecular characteristics of extended-spectrum beta-lactamases and qnr determinants in Enterobacter species from Japan. PLoS One. 2012;7:e37967.","journal-title":"PLoS One"},{"key":"2150_CR34","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/jac\/dkr283","volume":"66","author":"H Kanamori","year":"2011","unstructured":"Kanamori H, Yano H, Hirakata Y, Endo S, Arai K, Ogawa M, et al. High prevalence of extended-spectrum \u03b2-lactamases and qnr determinants in Citrobacter species from Japan: dissemination of CTX-M-2. J Antimicrob Chemother. 2011;66:2255\u201362.","journal-title":"J Antimicrob Chemother"},{"key":"2150_CR35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"GA Jacoby","year":"2009","unstructured":"Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009;22:161\u201382.","journal-title":"Clin Microbiol Rev"},{"key":"2150_CR36","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1128\/JCM.02111-09","volume":"48","author":"K Yamasaki","year":"2010","unstructured":"Yamasaki K, Komatsu M, Abe N, Fukuda S, Miyamoto Y, Higuchi T, et al. Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan. J Clin Microbiol. 2010;48:3267\u201373.","journal-title":"J Clin Microbiol"},{"key":"2150_CR37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/AAC.46.1.216-219.2002","volume":"46","author":"N Liassine","year":"2002","unstructured":"Liassine N, Madec S, Ninet B, Metral C, Fouchereau-Peron M, Labia R, et al. Postneurosurgical meningitis due to Proteus penneri with selection of a ceftriaxone-resistant isolate: analysis of chromosomal class A beta-lactamase HugA and its LysR-type regulatory protein HugR. Antimicrob Agents Chemother. 2002;46:216\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2150_CR38","volume-title":"Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20. Wayne: CLSI; 2010."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-2150-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T02:54:08Z","timestamp":1749869648000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-2150-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2150"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-2150-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2017,1,7]]},"article-number":"44"}}